Company Long-Term Loans and Borrowings: Telomir Pharma (TELO)

Public company logo of Telomir Pharma (TELO)

The share price of Telomir Pharmaceuticals (TELO) visualized below is based on an outsourcing model where substance synthesis and testing are delegated to external contractors, and the indicator stands at 0.00. Process continuity is ensured through laboratory diversification and the express delivery of components. However, global conflicts and the severance of trade ties create risks, complicating raw material procurement and the conduct of international longevity research.

TELO Telomir Pharmaceuticals Company Long-Term Debts (02/21/2024 - 11/01/2026)

Summary analytical data breakdowns for Telomir Pharma (TELO)

- market price and analyst price targets:
Stock Price telomirpharma.com|TELO - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Telomir Pharmaceuticals|TELO - Total Company Value
- book capitalization information:
Accounting Value per Share Telomir Pharmaceuticals|TELO - Book Capitalization|Market Capitalization to Book Value Ratio telomirpharma.com|TELO - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Telomir Pharmaceuticals|TELO - Long-Term Debt to Equity|Current Liabilities to Capital Telomir Pharmaceuticals Corp|TELO - Company Total Debt|Debt to Book Capital Telomir Pharmaceuticals|TELO - Company Long-Term Debts|Company Short-Term Loans and Borrowings Telomir Pharmaceuticals|Immediate Liquidity telomirpharma.com
- earnings and multiples data:
TELO - Company Net Income
Fundamental company valuation:telomirpharma.com TELO
Brand item of Telomir Pharmaceuticals, Inc.

A comparative analysis of long-term liabilities allows for an assessment of the company's capital stability relative to systemic liquidity. This metric aggregates all creditor obligations with a maturity exceeding one year, determining financial leverage and overpayment risks during valuation. For Telomir Pharmaceuticals (TELO), this long-term financial debt figure is critical, as scaling anti-aging technologies requires significant investment prior to product commercialization.

Who Telomir Pharmaceuticals competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Long-Term Debt|MNKD: Company Long-Term Liabilities|amphastar.com - Amount of Long-Term Liabilities|PCRX: Company Long-Term Debts|ARS Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|TBPH (Theravance) - Company Long-Term Debts|Long-Term Debt Aquestive Corp AQST|Company Long-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Long-Term Loans and Borrowings|Tonix Pharmaceuticals Holding Corp. - Company Long-Term Liabilities|Amount of Long-Term Liabilities SXTC (SXT Pharmaceuticals)|Eupraxia Pharma - Company Long-Term Debts|Long-Term Debt BioHarvest Sciences Inc|eXoZymes Inc (EXOZ) - Company Long-Term Debt|ORMP (Oramed Pharmaceuticals Inc.) - Company Long-Term Debt|Company Long-Term Debt Entera Bio Ltd|Long-Term Debt MindWalk Holdings, Inc. HYFT|Company Long-Term Debt ABVC BioPharma Inc (ABVC)|Company Long-Term Liabilities Cumberland Corp CPIX|Company Long-Term Debts QNTM (Quantum BioPharma Ltd)|Long-Term Debt Volume fibrogen.com (FGEN)|RANI - Company Long-Term Debt|Company Long-Term Loans and Borrowings SNYR (Synergy CHC Corp)|RLYB (rallybio.com) - Company Long-Term Liabilities|Lexaria Bioscience Corp. - Company Long-Term Loans and Borrowings|Company Long-Term Debt Pulmatrix, Inc.|Pheton - Long-Term Liabilities|Company Long-Term Debts APM|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debts IBO (Impact BioMedical Inc)|Company Long-Term Debts TNF Pharmaceuticals Inc. TNFA|YCBD - Company Long-Term Debt|Company Long-Term Loans and Borrowings PRFX (painreform.com)|altamiratherapeutics.com (CYTO) - Company Long-Term Debt|Company Long-Term Liabilities Lipella Pharmaceuticals Inc|OPTN (Optinose) - Company Long-Term Debts|Company Long-Term Debts Pieris Pharma|Company Long-Term Debts PROC|Company Long-Term Liabilities petrospharma.com PTPI|Company Long-Term Debts QLI (Qilian International Holding)|Acelyrin Inc. (SLRN) - Long-Term Debt|TFFP: Company Long-Term Liabilities